Syngenta has submitted a legal challenge to the European Commission’s decision to suspend the use of the neonicotinoid thiamethoxam on bee attractive crops.
Syngenta Chief Operating Officer, John Atkin, said: “We would prefer not to take legal action but have no other choice given our firm belief that the Commission wrongly linked thiamethoxam to the decline in bee health. In suspending the product, it breached EU pesticide legislation and incorrectly applied the precautionary principle.
“Since the EU suspension of thiamethoxam was announced, farmers and farmer organizations have expressed great concern that an extremely effective, low dose product will not be available to them and will have to be replaced by much less sustainable alternatives. Modern products like thiamethoxam are essential to address the challenge of increasing European food production and reducing the reliance on imports.”
Thiamethoxam is the active ingredient in Syngenta’s popular product Crusier, which is used as a seed treatment on oil seed rape and protects the crop against flea beetle and cabbage stem flea beetle during establishment.
Syngenta called on all stakeholders to concentrate on practical solutions to bee health, which most experts agree is damaged by disease, viruses and the loss of habitat and nutrition. The company confirmed its commitment to support the expansion of Operation Pollinator across Europe and the Bee Health Action Plan, which was published in April 2013.
Formore about bees take a look at
Restriction of the insecticide Fipronil
Signs of a bee recovery should have us all buzzing
Will neonicotinoid restrictions save the bees?